COS-1 Current Concepts I

Wednesday June 27, 2012, 0800-1000
Metro West

Objectives
At the end of this session, participants will be able to:

  • Compare and contrast new treatments for Age Related Macular Degeneration.
  • Describe a new group of systemic syndromes: Cerebroretinal microangiopathies.
  • Improve their surgical transition to phaco chop.
  • Discuss stem cell-based therapy of ocular surface disease.
  • Incorporate key messages from the Canadian Diabetic Retinopathy guidelines into their practice.

Guests
Tero Kivelä, MD, FEBO
Thomas A. Oetting, MS, MD
Ursula Schlötzer-Schrehardt, PhD

Canadian faculty
François Codère, MD
Philip L. Hooper, MD
G. Robert LaRoche, MD
W. Bruce Jackson, MD
Sherif El-Defrawy, MD		 Moderator
Allan R. Slomovic

0800Welcome
François Codère
0805Introduction
Allan R. Slomovic
0810to be confirmed
0820Discussion
0825Cerebroretinal microangiopathies: a novel group of systemic syndromes
Tero Kivelä
0835Discussion
0840Transition to phaco chop
Thomas A. Oetting
0850Discussion
0855Stem cell-based therapy of ocular surface diseases: novel approaches to expansion of adult stem cells in culture
Ursula Schlötzer-Schrehardt
0905Discussion
0910The new Canadian Diabetic Retinopathy guidelines
Philip L. Hooper
0920COS Awards of Excellence: paper and poster winners
G. Robert LaRoche
0945Lifetime Achievement Award: presented to W. Bruce Jackson
Presentation by Sherif El-Defrawy


Tero Kivelä, MD, FEBO


Thomas A. Oetting, MS, MD


Prof. Ursula Schlötzer-Schrehardt, PhD